Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
IL-4
DRUG
2 trials
Sponsors
National Cancer Institute (NCI)
Conditions
Ewing's Sarcoma
Leukemia, Acute Lymphocytic (ALL)
Leukemia, Acute Myelogenous (AML)
Leukemia, Chronic Myelogenous (CML)
Myelodysplastic Syndrome (MDS)
Non-Hodgkin's Lymphoma (NHL)
Rhabdomyosarcoma
Phase 1
Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
Completed
NCT00923910
National Cancer Institute (NCI)
Leukemia, Acute Lymphocytic (ALL), Leukemia, Acute Myelogenous (AML), Leukemia, Chronic Myelogenous (CML) +2
Start: 2008-02-22
End: 2016-11-15
Updated: 2017-04-12
Phase 2
A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas
Completed
NCT00001564
National Cancer Institute (NCI)
Ewing's Sarcoma, Rhabdomyosarcoma
Start: 1996-12-23
End: 2007-10-25
Updated: 2019-11-29